Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record.

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.

Bataille, Regis, Durie, Brian G. M., Grenierj, Jean · 1983 · British Journal of Haematology

Abstract

S ummary.Previous reports have shown serum beta 2 microglobulin (SB2M) to be a reliable marker for evaluation of presenting tumour mass, response to chemotherapy and prognosis of patients with multiple myeloma (MM). In the current study, SB2M was evaluated and correlated by bivariate and multivariate regression analyses with the main presenting clinical features, response to chemotherapy and survival duration of 115 untreated myeloma patients. In the bivariate analysis, there was a clear correlation between SB2M and myeloma stage (P= 0·002). Other interesting correlations were between SB2M and creatinine values (P< 0·001), SB2M and the likelihood of having lambda subtype (P< 0·001), high SB2M and high uric acid (P< 0·036), high SB2M and a low haemoglobin (P< 0·001). In the multivariate regression analyses, SB2M alone completely substituted for the effect of initial staging and gave a very reliable fit for survival prediction. Particularly noteworthy was the dramatic difference in survival duration observed between patients with a high pre‐treatment SB2M (> 6 μg/ml) and those with low SB2M: 26 months versus 52 months (P< 0·0001). We conclude that SB2M is the major determinant of survival in MM and can be used alone for effective pretreatment stratification of myeloma patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.1983.tb02158.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 177

Metadata

Authors
Bataille, R., Durie, B. G. M., & Grenierj, J.
Venue
British Journal of Haematology
Publisher
Wiley
Published
1983-11
Volume
55
Issue
3
Pages
439-447
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2119087732
Cited by
177
References
0
FWCI
5.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. https://app.cochat.ai/papers/10.1111/j.1365-2141.1983.tb02158.x
The paper
Bataille, R., Durie, B. G. M., & Grenierj, J. (1983). Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1983.tb02158.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.